Article Text

PDF

BAS/BSCR poster abstract
BAS/BSCR50 Effect of immunisation with Chlamydia pneumoniae recombinant major outer membrane protein on atherosclerosis development
  1. R El Kadri1,
  2. A Bermudez-Fajardo1,
  3. M Puolakkainen2,
  4. G Stewart1,
  5. E Oviedo-Orta1
  1. 1University of Surrey, Faculty of Health and Medical Sciences, Guildford, Surrey, UK
  2. 2Department of Viral Diseases and Immunology, NPHI, Helsinki, Finland

Abstract

The major outer membrane protein (MOMP) of Chlamydia pneumoniae is a 40 kDa porin and represents approximately 60% of the outer membrane protein pool. Previous studies have shown that MOMP can dampen down T-cell-mediated immune responses. We decided to assess if this effect could have an impact on atherosclerotic plaque development. We used recombinant Mycobacterium vaccae (M vaccae) vectors expressing MOMP (with and without signal sequence) to vaccinate ApoE−/− mice intranasally. Animals received one initial dose and two booster doses 3 weeks apart and continued with a standard Chow diet for another 4 weeks. Control mice received phosphate-buffered saline or were left untreated. Plasma collected before immunisation and at termination was used to measure levels of interferon γ, interleukin (IL)-4 and IL-10 and also IgG1 and IgG2b. Atherosclerotic plaque development was assessed using paraffin sections of the brachiocephalic artery. Our results show that intranasal administration of M vaccae vectors expressing MOMP, with or without signal sequence, promotes anti-atherogenic T-cell responses and halts the development and progression of atherosclerotic plaques in ApoE−/− mice.

    Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.